Tech Company Financing Transactions

Elo Life Systems Funding Round

Elo Life Systems, operating out of Durham, secured $24.5 million in investment from ACCELR8, DCVC Bio and Novo Holdings.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A

ACCELR8 (Lead Investor)

DCVC Bio (Lead Investor)

Novo Holdings (Lead Investor)

Proceeds Purpose
The company intends to use the funds to accelerate the development of its natural, plant-based sweeteners products by advancing U.S. regulatory approvals, building pilot-scale processing capabilities, and market-testing its sweetener with consumers.

Company Information

Company Status
Private & Independent
Life Sciences
Mailing Address
3054 East Cornwallis Rd
Durham, NC 27709
Email Address
Elo Life Systems is reimagining the future of food -- focusing on ingredients that empower consumers to feel good about the food they eat every day. From unique plant-based sweeteners to saving crops like the banana from extinction,
Elo Life Systems LinkedIn Company Profile
Social Media
Elo Life Systems Company Twitter Account
Company News
Elo Life Systems News
Elo Life Systems on Facebook
Elo Life Systems on YouTube

Management Team

Email & Social
Chief Executive Officer
Todd Rands
  Todd Rands LinkedIn Profile  Todd Rands Twitter Account  Todd Rands News  Todd Rands on Facebook
Chief Operating Officer
Paul Boyer
  Paul Boyer LinkedIn Profile  Paul Boyer Twitter Account  Paul Boyer News  Paul Boyer on Facebook



Browse more venture capital transactions:

Prev: 2/15/2023: Vaas venture capital transaction
Next: 2/15/2023: Kanarys venture capital transaction


Share this article


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary